Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01385982 · ClinicalTrials.gov registry record · Phase 3
Improving Management of Outpatient Actionable Test Results
A Phase 3 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 6,000
- Enrollment target
NCT01385982: Completed Phase 3 study, sponsored by Brigham and Women's Hospital.
NCT01385982 is a Phase 3 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 6,000 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (677% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01385982, a Phase 3 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 6,000 participants
- Enrollment target
Study Summary
Clinically significant test results require timely clinician follow-up including the non-urgent clinically significant, or actionable, test results that have received less standardized management and attention. Unfortunately, failure to correctly manage actionable test results is not infrequent and may be associated with important delays in diagnosis and treatment and patient harm. The investigators have designed a safe practice intervention to improve the management of actionable test results for ambulatory patients in a large healthcare system.
Primary Outcome
The primary outcome of interest is the proportion of sub-critical/abnormal (Level 3 Laboratory and Level 2 Cardiology) ATRs documented as acknowledged by the responsible clinician and having appropriate, follow-up action(s).
Interventions
- OTHER Actionable Test Result Management/Standardization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,000 participants |
| Start Date | 2011-07 |
| Est. Completion | 2013-01 |
| Phase | Phase 3 |
What the finished NCT01385982 record still lists
NCT01385982 is an interventional study that assigns participants to a tested intervention. Its 6,000 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (677% higher).
The record links to 0 conditions, and to 1 intervention - of which Actionable Test Result Management/Standardization is the first listed.
NCT01385982 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01385982 about?
NCT01385982 is a clinical study titled "Improving Management of Outpatient Actionable Test Results". Clinically significant test results require timely clinician follow-up including the non-urgent clinically significant, or actionable, test results that have received less standardized management and attention. Unfortunately, failure to correctly manage actionable test results is not infrequent and ...
What is the current status of trial NCT01385982?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 6,000 participants. The study started on 2011-07. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01385982?
The interventions under investigation include: Actionable Test Result Management/Standardization (OTHER).
Who is sponsoring clinical trial NCT01385982?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01385982's enrollment target sits among peer trials
6,000 37th of 2000 higher than 1,961 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
- NCT03127631 · 6,000 participants · NA
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
- NCT03539705 · 6,000 participants
Food Allergy Registry at a Single Site
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia